Image

Global Proliferative Diabetic Retinopathy Market – Industry Trends and Forecast to 2029

Healthcare

Image

Global Proliferative Diabetic Retinopathy Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Aug 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Proliferative Diabetic Retinopathy Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 1,969.07 USD Million
Diagram Market Size (Forecast Year) USD 3,617.70 USD Million
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Proliferative Diabetic Retinopathy Market, By (Drug Class - Anti-VEGF Agents, and Corticosteroids), Mode of Administration (Injectables, Oral, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)– Industry Trends and Forecast to 2029

Proliferative Diabetic Retinopathy Market

Proliferative Diabetic Retinopathy Market Analysis and Size

According to the Centers for Disease Control and Prevention, 655,000 persons with diabetic retinopathy and approximately 4.2 million adults overall have the condition. Additionally, rising healthcare costs and a solid healthcare infrastructure significantly boost the growth of the regional market as a whole.

Data Bridge Market Research analyses that the proliferative diabetic retinopathy market which was USD 1969.07 million in 2021, would rocket up to USD 3617.70 million by 2029, and is expected to undergo a CAGR of 7.90% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

(Drug Class - Anti-VEGF Agents, and Corticosteroids), Mode of Administration (Injectables, Oral, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

?nt?? ?h?rm???ut???l? Ltd. (India), N?v?rt?? AG (Switzerland), ?f?z?r Inc. (U.S.), Kowa Company, Ltd. (Japan), Sirnaomics (U.S.), Glycadia Pharmaceuticals (U.S.), BCN Peptides (Spain), Santen Pharmaceutical Co., Ltd. (Japan), Alimera Sciences (U.S.), Ampio Pharmaceuticals Inc. (U.S.), ThromboGenics NV (Belgium), Bayer AG (Germany)

Market Opportunities

  • Increase in prevalence of diabetes
  • Rise in geriatric population

Market Definition

Proliferative diabetic retinopathy is a consequence of diabetes brought on by alterations in the blood vessels of the eyes. If left untreated, this condition can result in additional serious eye conditions and long-term vision loss. The most severe form of diabetic retinopathy, proliferative diabetic retinopathy, is characterised by the development of new blood vessels on the retina's surface.

Proliferative Diabetic Retinopathy Market Dynamics

Drivers

  • Rise in demand of angiogenesis

Angiogenesis will play a significant role in the aetiology of proliferative diabetic retinopathy, and intravitreal antiangiogenic injection has been proposed as a potential treatment for the condition. Proliferative diabetic retinopathy is being effectively treated using a variety of antiangiogenic strategies, which will likely play crucial roles in the treatment and prevention of the condition in the next years.

  • Rise in disposable income

Consumers' increasing disposable income and worries about vision loss have had an impact on how much money patients are willing to spend on the essential therapy for diabetic retinopathy. Patients with proliferative diabetic retinopathy may be more inclined to choose surgical therapies if there is access to cutting-edge technology and minimally invasive laser therapy that also offers quicker recovery.

Opportunities

Globally, the geriatric population has been growing significantly, and this population segment is particularly vulnerable to many chronic diseases including diabetes. Therefore, older people are more likely to acquire proliferative diabetic retinopathy. This has increased the need for efficient medications to treat proliferative diabetic retinopathy in the elderly population.

Restraints/Challenges

  • Strignent guidelines

The pandemic has fundamentally altered how many industries and enterprises are growing. The supply chain systems have been severely hampered by the border restrictions and the rigorous stay-at-home orders. Thus, all these aspects have negatively influenced the growth of the proliferative diabetic retinopathy market. 

This proliferative diabetic retinopathy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the proliferative diabetic retinopathy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Proliferative Diabetic Retinopathy Market

The global market for proliferative diabetic retinopathy is expected to suffer as a result of the COVID-19 epidemic. Globally, the COVID-19 outbreak has impacted healthcare industry workflows. As ophthalmological care is heavily dependent on specialised imaging equipment that is not readily available outside of ophthalmologists' offices, which is impeding market growth. Ophthalmic outpatient visits were largely reduced to urgent and emergent cases only, and the procedures and operations were postponed.

Global Proliferative Diabetic Retinopathy Market Scope

The proliferative diabetic retinopathy market is segmented on the basis of type, mode of administration and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

????

  • ?nt?-V?GF ?g?nt?
  • ??rt????t?r??d?

Mode of Administration

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Proliferative Diabetic Retinopathy Market Regional Analysis/Insights

The proliferative diabetic retinopathy market is analysed and market size insights and trends are provided by country, type, mode of administration and distribution channel as referenced above.

The countries covered in the proliferative diabetic retinopathy market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the market due to growing prevalence of diabetes and diabetic retinopathy.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the growing health awareness among the people.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Proliferative Diabetic Retinopathy Market Share Analysis

The proliferative diabetic retinopathy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to proliferative diabetic retinopathy market.

Some of the major players operating in the proliferative diabetic retinopathy market are:

  • ?nt?? ?h?rm???ut???l? Ltd. (India)
  • N?v?rt?? AG (Switzerland)
  • ?f?z?r Inc. (U.S.)
  • Kowa Company, Ltd. (Japan)
  • Sirnaomics (U.S.)
  • Glycadia Pharmaceuticals (U.S.)
  • BCN Peptides (Spain)
  • Santen Pharmaceutical Co., Ltd. (Japan)
  • Alimera Sciences (U.S.)
  • Ampio Pharmaceuticals Inc. (U.S.)
  • ThromboGenics NV (Belgium)
  • Bayer AG (Germany)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The proliferative diabetic retinopathy market value was USD 1969.07 million in 2021.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials